Mandeep R. Mehra
The Journal of Heart and Lung Transplantation · 2006–2020
A researcher in the Science corpus: 16 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Mandeep R. Mehra trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Mandeep R. Mehra overall
Papers from Mandeep R. Mehra's perspective
Ordered by how strongly the researchers Mandeep R. Mehra trusts endorse each paper. Same corpus, a different order for every researcher.
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury (The Lancet)
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. (The Lancet)
- The mechanisms of action of PPARs. (Annual Review of Medicine)
- Blood levels of long-chain n-3 fatty acids and the risk of sudden death. (New England Journal of Medicine)
- Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. (Journal of the American Medical Association (JAMA))
- Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy (Circulation)
- Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. (Journal of Clinical Oncology)
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review (British medical journal)
- Frailty in elderly people. (The Lancet)
- Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. (The Journal of Heart and Lung Transplantation)
Their papers
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 (2020) — 1,076 citations
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal (2020) — 1,564 citations
- Extrapulmonary manifestations of COVID-19 (2020) — 2,748 citations
- Endothelial cell infection and endotheliitis in COVID-19 (2020) — 5,643 citations
- Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (2020) — 643 citations
- RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (2020) — 731 citations
- A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report (2019) — 982 citations
- Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association (2018) — 656 citations
- Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure (2018) — 616 citations
- A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure (2017) — 650 citations
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. (2016) — 1,265 citations
- Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. (2013) — 603 citations
- International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. (2010) — 905 citations
- Omega-3 polyunsaturated fatty acids and cardiovascular diseases. (2009) — 596 citations
- HFSA 2006 comprehensive heart failure practice guideline (2006) — 833 citations
- Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. (2006) — 946 citations